Imatinib Mesylate
Rank #181 of 500 drugs by total cost
Data: CMS Medicare Part D, 2023 (most current available) · Updated March 2026
$85.0M
Total Cost
40,908
Total Claims
$85.0M
Total Cost
1,931
Prescribers
$2,079
Cost per Claim
215
Beneficiaries
42,531
30-Day Fills
$44K
Avg Cost/Provider
21
Avg Claims/Provider
Share of Medicare Part D Spending
0.03%
of total Medicare Part D spending
$85.0M of $275.65B
Top Prescribers by Cost
Top 10 prescribers of $85.0M total
🔎 Data Overview
At $2,079 per prescription, this is a high-cost medication. Expensive drugs drive Medicare spending growth and create access challenges for patients with coverage gaps.
Average cost of $395,481 per patient per year. Medications at this price point significantly impact patient out-of-pocket costs and Medicare spending.
Insights generated from CMS data analysis. Statistical patterns are not accusations — always consider clinical context.
Top Prescribers of Imatinib Mesylate
| # | Provider | Specialty | Location | Claims | Cost |
|---|---|---|---|---|---|
| 1 | Morgan Mount | Nurse Practitioner | Miami, FL | 36 | $466K |
| 2 | Margaret Von-Mehren | Hematopoietic Cell Transplantation and Cellular Therapy | Philadelphia, PA | 24 | $414K |
| 3 | Nitin Kapoor | Internal Medicine | Washington, PA | 82 | $315K |
| 4 | Mrinal Gounder | Medical Oncology | New York, NY | 25 | $307K |
| 5 | Reema Patel | Medical Oncology | Lexington, KY | 153 | $306K |
| 6 | Daniel Deangelo | Medical Oncology | Boston, MA | 72 | $290K |
| 7 | Bashar Alasad | Medical Oncology | Oklahoma City, OK | 14 | $281K |
| 8 | Tony Philip | Hematology-Oncology | New Hyde Park, NY | 77 | $277K |
| 9 | Ravi Bhatia | Hematology-Oncology | Duarte, CA | 83 | $270K |
| 10 | Noman Rafique | Hematology-Oncology | Massillon, OH | 24 | $261K |
| 11 | Karlton Wong | Medical Oncology | Burbank, CA | 16 | $259K |
| 12 | Margaret Von-Mehren | Hematopoietic Cell Transplantation and Cellular Therapy | Philadelphia, PA | 136 | $255K |
| 13 | Craig Devoe | Hematology | Lake Success, NY | 16 | $245K |
| 14 | Shadi Haddadin | Hematology-Oncology | Jefferson City, MO | 66 | $241K |
| 15 | Inder Lal | Hematology-Oncology | Amsterdam, NY | 29 | $239K |
Top prescribers ranked by total cost for this drug in 2023.
Related Drugs by Cost
| # | Drug | Total Cost | Claims |
|---|---|---|---|
| 178 | Insulin Aspart Prot/Insuln Asp (Novolog Mix 70-30 Flexpen) | $88.8M | 79,814 |
| 179 | Teduglutide (Gattex) | $88.4M | 1,758 |
| 180 | Galcanezumab-Gnlm (Emgality Pen) | $87.0M | 101,221 |
| 181 | Imatinib Mesylate (Imatinib Mesylate) | $85.0M | 40,908 |
| 182 | Clopidogrel Bisulfate (Clopidogrel) | $84.7M | 5,428,304 |
| 183 | Famotidine (Famotidine) | $84.3M | 5,257,365 |
| 184 | Mifepristone (Korlym) | $83.3M | 2,397 |
Related Analysis
Data from CMS Medicare Part D Prescriber-Drug Public Use File, 2023. Methodology